Emergence of Long COVID: Threat to Humanity Persists!
Downloads
Published
DOI:
https://doi.org/10.56450/JEFI.2024.v2i03.005Keywords:
COVID-19, Epidemiology, Brain Fog, Dyspnea, Fatigue, CoronavirusIssue
Section
License
Copyright (c) 2024 Kaushik Bharati
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The transition of COVID-19 from a pandemic to an endemic disease will result in the further spread of SARS-CoV-2 among the vulnerable populations, especially those who still remain unvaccinated. Thus, infections are destined to increase and the majority of humanity will become infected within a short span of time. As with most viral infections, post-infection sequelae are a reality for COVID too. In fact, it has already been observed that 10-20% of COVID patients who have fully recovered, go on to develop lingering symptoms that persist for a long period of time. This has been termed as long COVID or post-COVID condition. This underscores the fact that the danger still looms and we’re not out of the woods yet. The present review article highlights the major facets of long COVID and suggests possible remedial measures that could make it a thing of the past.Abstract
How to Cite
Author Biography
Kaushik Bharati, Health Policy Consultant – UNESCO, New Delhi
.
Estrada LV, Levasseur JL, Maxim A, Benavidez GA, Porter KMP. Structural racism, place, and COVID-19: A narrative review describing how we prepare for an endemic COVID-19 future. Health Equity. 2022; 6(1): 356-66. Worldometer Coronavirus Tracker. Available at: https://www.worldometers.info/coronavirus/; Accessed on: 16.05.2024. Reese H, Luliano AD, Patel NN, Garg S, Kim L, Silk BJ, et al. Estimated incidence of coronavirus disease 2019 (COVID-19) illness and hospitalization - United States, February-September 2020. Clin Infect Dis. 2021; 72(12): e1010-e1017. Garg P, Arora U, Kumar A, Wig N. The “post-COVID” syndrome: How deep is the damage? J Med Virol. 2021; 93(2): 673-4. Katsoularis I, Fonseca-Rodriguez O, Farrington P, Jerndal H, Lundevaller EH, Sund M, et al. Risks of deep vein thrombosis, pulmonary embolism, and bleeding after COVID-19: Nationwide self-controlled cases series and matched cohort study. BMJ. 2022; 377. Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022; 28: 583-60. Bhaskaran K, Rentsch CT, Hickman G, Hulme WJ, Schultze A, Curtis HJ, et al. Overall and cause-specific hospitalisation and death after COVID-19 hospitalisation in England: A cohort study using linked primary care, secondary care, and death registration data in the OpenSAFELY platform. PLoS Med. 2022; 19: e1003871. Roca-Fernandez A, Wamil M, Telford A, Carapella V, Borlotti A, Monteiro D, et al. Cardiac abnormalities in Long COVID 1-year post-SARS-CoV-2 infection. Open Heart. 2023; 10(1): e002241. Malkova A, Kudryavtsev I, Starshinova A, Kudlay D, Zinchenko Y, Glushkova A, et al. Post COVID-19 syndrome in patients with asymptomatic/mild form. Pathogens. 2021; 10: 1408. Groff D, Sun A, Ssentongo AE, Ba DM, Parsons N, Poudel GR, et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: A systematic review. JAMA Netw Open. 2021; 4(10): e2128568. Huang L, Yao Q, Gu X, Wang Q, Ren L, Wang Y, et al. 1-year outcomes in hospital survivors with COVID-19: A longitudinal cohort study. Lancet. 2021; 398: 747-58. Ayoubkhani D, Khunti K, Nafilyan V, Maddox T, Humberstone B, Diamond I, et al. Post-COVID syndrome in individuals admitted to hospital with COVID-19: Retrospective cohort study. BMJ. 2021; 372: n693. Ayoubkhani D, Pawelek P, Gaughan C. Technical article: Updated estimates of the prevalence of post-acute symptoms among people with coronavirus (COVID-19) in the UK: 26 April 2020 to 1 August 2021 - Office for National Statistics, 2021. Ballering AV, van Zon SKR, Hartman TCO, Rosmalen JGM; Lifelines Corona Research Initiative. Persistence of somatic symptoms after COVID-19 in the Netherlands: An observational cohort study. Lancet. 2022; 400(10350): 452-61. Greenhalgh T, Knight M, A’Court C, Buxton M, Husain L. Management of post-acute COVID-19 in primary care. BMJ. 2020; 370: m3026. Geddes L. Why strange and debilitating coronavirus symptoms can last for months. New Sci. 2020. Available at: https://www.newscientist.com/article/mg24632881-400-why-strange-and-debilitatingcoronavirus-symptoms-can-last-for-months/; Accessed on 17.05.2024. Nabavi N. Long COVID: How to define it and how to manage it. BMJ. 2020; 370: m3489. Carfi A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. J Am Med Assoc. 2020; 324(6): 603-5. Arnold DT, Hamilton FW, Milne A, Morley AJ, Viner J, Attwood M, et al. Patient outcomes after hospitalization with COVID-19 and implications for follow-up: Results from a prospective UK cohort. Thorax. 2021; 76(4): 399-401. Tenforde MW, Kim SS, Lindsell CJ, Rose EB, Shapiro NI, Files DC, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network - United States, March-June 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(30): 993-8. Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci Rep. 2021; 11(1): 16144. Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med. 2021; 27(4): 626-31. Tay MZ, Poh CM, Renia L, MacAry PA, Ng LFP. The trinity of COVID-19: Immunity, inflammation and intervention. Nat Rev Immunol. 2020; 20(6): 363-74. Biehl M, Sese D. Post-intensive care syndrome and COVID-19 - Implications post pandemic. Cleve Clin J Med. August 5, 2020 (ahead of print). Gemelli Against COVID-19 Post-Acute Care Study Group. Post-COVID-19 global health strategies: The need for an interdisciplinary approach. Aging Clin Exp Res. 2020; 32: 1613-20
References
